The global open angle glaucoma market is expected to grow at a significant CAGR during the forecast period (2021-2027). Glaucoma is an optical illness that can cause vision loss and optic nerve damage. Closed angle, open angle, and normal tension glaucoma are the three kinds of glaucoma. The most prevalent type of glaucoma is open angle glaucoma, often known as wide angle glaucoma. Glaucoma is defined by an increase in intraocular pressure that results in optic nerve damage. Optic nerve dysfunction can result in permanent vision loss. Glaucoma, along with other illness conditions such as diabetes, is more common in the elderly population. Family history, obesity, high blood pressure, diabetes, increased eye pressure, migraines, and other conditions are all risk factors for glaucoma. Loss of peripheral vision, eye redness, eye pain, and limited vision are all symptoms of glaucoma.

Open angle glaucoma is painless and progresses progressively over time. Closed angle glaucoma, on the other hand, can develop suddenly. Eye pain, blurred vision, dilated pupils, and redness is all symptoms of this rapid occurrence. Topical eye drops from drug classes such as beta blockers, prostaglandins, carbonic anhydrase inhibitors, cholinergic medicines, alpha agonists, and combination therapy are used to treat open angle glaucoma. Topical eye drops might be used as a substitute for surgery or to postpone it. During the forecast period, the global open angle glaucoma market is expected to rise due to rising knowledge regarding the early identification of glaucoma and economical treatment choices. The market is being driven by an increase in the senior population, a rise in the diabetic population, increased awareness and cheap costs, new creative medicine combinations, and an increase in the number of myopia cases.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi US, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Open Angle Glaucoma Market by Segment

By Drug Class

• Beta Blockers

• Prostaglandins

• Carbonic Anhydrase Inhibitor

• Cholinergic Drugs

• Alpha Agonist

• Combined Medication 

By Distribution Channel 

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy 

Global Open Angle Glaucoma Market by Region